Therapy-induced senescence is a transient drug resistance mechanism in breast cancer

Bajtai, Eszter and Kiss, Csaba and Bakos, Éva and Langó, Tamás and Lovrics, Anna and Schád, Éva and Tisza, Viktoria and Hegedűs, Károly and Fürjes, Péter and Szabó, Zoltán and Tusnády, Gábor and Szakács, Gergely and Tantos, Ágnes and Spisák, Sándor and Tóvári, József and Füredi, András (2025) Therapy-induced senescence is a transient drug resistance mechanism in breast cancer. MOLECULAR CANCER, 24 (1). ISSN 1476-4598

Preview

Text s12943-025-02310-0.pdf - Published Version Available under License Creative Commons Attribution. Download (6MB) | Preview

Abstract

Therapy-induced senescence (TIS) is considered a permanent cell cycle arrest following DNA-damaging treatments; however, its irreversibility has recently been challenged. Here, we demonstrate that escape from TIS is universal across breast cancer cells. Moreover, TIS provides a reversible drug resistance mechanism that ensures the survival of the population, and could contribute to relapse.TIS was induced in four different breast cancer cell line with high-dose chemotherapy and cultured until cells escaped TIS. Parental, TIS and repopulating cells were analyzed by bulk and single-cell RNA sequencing and surface proteomics. A genetically engineered mouse model of triple-negative breast cancer was used to prove why current senolytics cannot overcome TIS in tumors.Screening the toxicity of a diverse panel of FDA-approved anticancer drugs revealed that TIS meditates resistance to half of these compounds, despite their distinct mechanism of action. Bulk and single-cell RNA sequencing, along with surface proteome analysis, showed that while parental and repopulating cells are almost identical, TIS cells are significantly different from both, highlighting their transient nature. Furthermore, investigating dozens of known drug resistance mechanisms offered no explanation for this unique drug resistance pattern. Additionally, TIS cells expressed a gene set associated with immune evasion and a potential KRAS-driven escape mechanism from TIS.Our results reveal that TIS, as a transient drug resistance mechanism, could contribute to overcome the immune response and to relapse by reverting to a proliferative stage.

Actions (login required)

Edit Item